Diabetic nephropathy: Changes after diabetes surgery?;Nefropatïa Diabëtica: ¿cambia tras la cirugía de diabetes?

Nutricion Hospitalaria

Volumn 28, Issue SUPPL2, 2013, Pages 57-65

  Ros Ruiz, S ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Chronic kidney disease; Microalbuminuria; Obesity; Proteinuria; Weight loss

Indexed keywords

BARIATRIC SURGERY; CHRONIC KIDNEY FAILURE; DIABETIC NEPHROPATHY; HUMAN; OBESITY; REVIEW; RISK FACTOR;

BARIATRIC SURGERY; DIABETIC NEPHROPATHIES; HUMANS; OBESITY; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84876428578     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2013.28.sup2.6568     Document Type: Article

References (55)

1. Keidar A. Bariatric Surgery for Type 2 Diabetes reversal: The risks. Diabetes Care 2011; 34 (2): S361-S366.
2. Yoo KH, Lee JH, Kim JW et al. Epidemic obesity and type 2 diabetes in Asia. The Lancet 2006; 368 (11): 1681-1688.
3. Dixon JB. Pories WJ, O'Brien PE, Schauer PR, Zimmet P. Surgery as an effective early intervention for Diabesity. Diabetes Care 2005; 28 (2): 472-474.
4. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS. Prevalence of Obesity, Diabetes, and Obesity-related Health Risk Factors, 2001. JAMA 2003; 289 (1): 76-79.
5. Zalesin KC., and McCullough PA. Bariatric surgery for Morbid Obesity: Risks and Benefits in Chronic Kidney Disease patients. Adv Chronic Kid Dis 2006; 13 (4): 403-417.
6. Bouldin MJ, Ross LA, Sumrall CD, Loustalot FV, Low A, Land KK. The effect of obesity surgery on obesity comorbidity. Am J Med Sci 2006; 331 (4): 183-193.
7. Pories WJ. Diabetes: the evolution of a new paradigm. Ann Surg 2004: 12-13.
8. Nandagopal R, Brown RJ, Rother KI. Resolution of Type 2 Diabetes following bariatric surgery: Implications for adults and adolescents. Diab Tech Ther 2010; 12 (8): 671-677.
9. Lebovitz HE. Type 2 diabetes mellitus-current therapies and the emergence of surgical options. Nature 2011; 7: 408-419.
10. Griffin KA, Kramer H, Bidani AK. Adverse renal consequences of obesity. Am J Physiol Renal Physiol 2008; 294: F685-F696.
11. Hsu C, Bates DW, Kuperman GJ. Diabetes, hemoglobin A1c, cholesterol and risk of moderate chronic renal insufficiency in ambulatory population. Am J Kidney Dis 2000; 36: 272-281.
12. Bakris GL. Recognition, Pathogenesis, and treatment of different stages of Nephropathy in patients with Type 2 Diabetes Mellitus. Mayo Clin Proc 2011; 86 (5): 444-456.
13. Gaede P, Vedel P, Larsen N et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383-393.
14. Eknoyan G. Obesity and chronic kidney disease. Nefrologia 2011; 31 (4): 397-403.
15. DeJong PE, Verhave JC, Pinto-Sietsma SJ, Hillege HL, PREVEND Study Group. Obesity and target organ damage: the kidney. Int J Obesity 2002; 26 (Suppl. 4): S21-S24.
16. Mykkanen L, Zaccaro DJ, Wagenknecht LE et al. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance aterosclerosis study. Diabetes 1998; 47: 793-800.
17. De Zeeuw D, Remuzzi G, Parving HH et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 2004; 110: 921-927.
18. Kohler KA, McClellan WM, Ziemer DC, Kleinbaum DG, Boring JR. Risk factors for microalbuminuria in black Americans with newly diagnosed type 2 diabetes. Am J Kidney Dis 2000; 36: 903-913.
19. Morales E, Valrro Ma, León M, Hernández E, Praga M. Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis 2003; 41: 319-329.
20. Praga M, Morales E. Obesity-related renal damage: changing diet to avoid progression. Kidney Int 2010; 78: 633-635.
21. Afshinnia F, Wilt TJ, Duval S, Esmaeili A. Weight loss and proteinuria: systemic review of clinical trials and comparative cohorts. Nephrol Dial Transpl 2010; 25: 1173-1183.
22. Klein S, Sheard NF, Pi-Sunyer X et al. Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies: a statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. Diabetes Care 2004; 27 (8): 2067-2073.
23. National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 2007; 49 (Suppl. 2): S12-S154.
24. Serra A, Granada ML, Romero R et al. The effect of bariatric surgery on adipocytokines, renal parameters and other cardiovascular risk factors in severe and very severe obesity: 1-year follow-up. Clin Nutr 2006; 25 (3): 400-408.
25. Navarro-Díaz M, Serra A, Romero R et al. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up. J Am Soc Nephrol 2006; 17 (Suppl. 3): S213-S217.
26. Agrawal V, Khan I, Rai B et al. The effect of weight loss after bariatric surgery on albuminuria. Clin Nephrol 2008; 70 (3): 194-202.
27. Saliba J, Kasim NR, Tamboli RA et al. Roux-en-Y gastric bypass reverses renal glomerular but not tubular abnormalities in excessively obese diabetics. Surgery 2010; 147 (2): 282-287.
28. Chagnac A, Weinstein T, Herman M et al. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 2003; 14 (6): 1480-1486.
29. Alexander JW, Goodman HR, Hawver LR et al. Improvement and stabilization of chronic kidney disease after gastric bypass. Surg Obes Relat Dis 2009; 5 (2): 237-241.
30. Izzedine H, Coupaye M, Reach I et al. Gastric bypass and resolution of proteinuria in an obese diabetic patient. Diabet Med 2005; 22 (12): 1761-1762.
31. Cuda SP, Chung MH., Demunzio TM et al. Reduction of proteinuria after gastric bypass surgery: case presentation and management. Surg Obes Relat Dis 2005; 1 (1): 64-66.
32. Fowler SM, Kon V, Ma L et al. Obesity-related focal and segmental glomerulosclerosis: normalization of proteinuria in an adolescent after bariatric surgery. Pediatr Nephrol 2009; 24 (4): 851-855.
33. Agnani S, Vachharajani VT, Gupta R et al. Does treating obesity stabilize chronic kidney disease? BMC Nephrol 2005; 6 (1): 7.
34. Soto FC, Higa-Sansone G, Copley JB et al. Renal failure, glomerulonephritis and morbid obesity: improvement after rapid weight loss following laparoscopic gastric bypass. Obes Surg 2005; 15 (1): 137-140.
35. Tafti BA, Haghdoost M, Alvarez L et al. Recovery of renal function in a dialysis-dependent patient following gastric bypass surgery. Obes Surg 2009; 19 (9): 1335-1339.
36. Alexander JW, Goodman HR, Gersin K, Cardi M, Austin J et al. Gastric Bypass in morbidly obese patients with chronic renal failure and kidney transplant. Transplantation 2004; 78 (3): 469-474.
37. MacLaughlin HL, Halla WL, Patel AG, Macdougall IC. Laparoscipic sleeve gastrectomy is a novel and effective treatment for obesity in patients with chronic kidney disease. Obes Surg 2012; 22: 119-123.
38. Kalantar-Zadeh K, Abbott KC, Salahudeen AK et al. Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005; 81 (3): 543-554.
39. Currie A, Chetwood A, Ahmed AR. Bariatric surgery and renal function. Obes Surg 2011; 21: 528-539.
40. Kaizu Y, Tsunega T, Sakao T et al. Overweight as another nutritional risk factor for the long-term survival of non-diabetic hemodialysis patients. Clin Nephrol 1998; 50: 44-50.
41. Meier-Kriesche HU, Arndorfer JA, Kaplan B. The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation 2002; 73 (1): 70-74.
42. Rex IH, Hull D, Trowbridge E. Gastroplasty for morbid after cardiac and renal transplantation. Obes Surg 1991; 1: 439-442.
43. Maarterre WF, Hariharan S, First MR et al. Gastric bypass in morbidity obese kidney transplant recipient. Clin Transplant 1996; 10: 414-419.
44. Weiss H, Nehoda H, Labeck B, Oberwalder M, Aigner F et al. Organ Transplantation and obesity: evaluation, risks and benefits of therapeutics strategies. Obes Surg 2000; 10: 465-469.
45. Newcombe V, Blanch A, Slater GH et al. Laparoscopic adjustable gastric banding prior to renal transplantation. Obes Surg 2005; 15: 567-570.
46. Buch KE, El-Sabrout R and Brutt KM. Complications of laparoscopic gastric banding in renal transplantation recipients: a case study. Transplant Proc 2006; 38 (9): 3109-3111.
47. Takata MC, Campos GM, Ciovica R et al. Laparoscopic bariatric surgery improves candidacy in morbidly obese patients awaiting transplantation. Surg Obes Relat Dis 2008; 4 (2): 159-164.
48. Modanlou KA, Muthyala U, Xiao HL et al. Bariatric surgery among kidney transplant candidates and recipients: analysis of the United States Renal Data System and Literature review. Transplantation 2009; 87 (8): 1167-1173.
49. Koshy AN, Coombes JS, Wilkinson S, Fassett RG. Laparoscopic gastric banding surgery performed in obese dialysis patients prior to kidney transplantation. Am J Kid Dis 2008; 52 (4): e15-e17.
50. Szomstein S, Rojas R, Rosenthal RJ. Outcomes of Laparoscopic bariatric surgery after Renal Transplant. Obes Surg 2010; 20: 383-385.
51. Pedersen T, Eliasen K, Henriksen E. A prospective study of mortality associated with anesthesia and surgery: Risk indicators of mortality in hospital. Acta Anaesthesiol Scand 1990; 34: 176-182.
52. De Olveira LD, Dniz MT, de Fatima HSDM et al. Rhabdomyolysis after bariatric surgery by Roux-en-Y gastric bypass: a prospective study. Obes Surg 2009; 19 (8): 1102-1107.
53. Ahmed MH, Byrne CD. Bariatric surgery and renal function: a precarious balance between benefit and harm. Nephrol Dial Transplant 2010; 25: 3142-3147.
54. Semins MJ, Asplin JR, Steele K et al. The effect of restrictive bariatric surgery on urinary stone risk factors. Urology 2010; 76 (4): 826-829.
55. Nasr SH, D'Agati VD, Said SM et al. Oxalate nephropathy complic 3: 1676-1683.